Advertisment ACS-IndiaSymposium
 
Journal of Pharmaceutical Negative Results
  Print this page Email this page Small font sizeDefault font sizeIncrease font size 
Search Article 
  
Advanced search 
 Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts  
 
ORIGINAL ARTICLE
Year : 2016  |  Volume : 7  |  Issue : 1  |  Page : 37-41

A study of adherence of drug promotional literatures from various clinical specialties to the World Health Organization ethical criteria for drug promotion


1 Undergraduate Student, Kasturba Medical College, Manipal University, Mangalore, Karnataka, India
2 Department of Pharmacology, Kasturba Medical College, Manipal University, Mangalore, Karnataka, India

Correspondence Address:
Ashwin Kamath
Department of Pharmacology, Kasturba Medical College, Manipal University, Mangalore - 575 001, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0976-9234.177063

Rights and Permissions

Introduction: Doctors-prescribing practices are influenced by drug promotional activities. Studies have shown that drug promotional literatures (DPLs) do not conform to the established regulations in many countries. However, whether the non-conformance is more likely in a particular clinical specialty needs to be determined. The objective of our study was to assess the adherence of DPLs sampled from various clinical specialties to the World Health Organization (WHO) criteria for ethical drug promotion and determine the presence of any difference. Methodology: Thirty DPLs were collected from each of the five clinical specialty clinics (General Medicine, Surgery, Obstetrics and Gynecology, Pediatrics and Psychiatry) of a University Teaching Hospital. Each promotional literature was evaluated for adherence to the individual WHO ethical criteria's for drug promotion. Results: More than 80% of the promotional literatures from all the clinical specialties did not contain information on dosage modification, contraindications, precautions, adverse effects, drug interactions, drug over dosage, excipients, storage and shelf-life, and legal category of the drugs. Nearly 19.33% of the DPL were for vitamins, minerals, and nutritional supplements; 13.33% for antimicrobials and 10% for anti-anxiety medications. Conclusions: Our study shows that most of the DPLs across clinical specialties failed to adhere to many of the WHO criteria of ethical drug promotion. The information lacking in the DPLs is critical for rational decision making. Considering that these irregularities are present across clinical specialties, it is important to strengthen the regulations governing drug promotion.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1417    
    Printed13    
    Emailed0    
    PDF Downloaded58    
    Comments [Add]    

Recommend this journal